Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Role of Serum Circulating Microbial Toxins in Severity and Cytokine Storm of Covid Positive Patients Publisher Pubmed



Fallah A1 ; Sedighian H2 ; Behzadi E3 ; Havaei SA4 ; Kachuei R5 ; Imani Fooladi AA2
Authors

Source: Microbial Pathogenesis Published:2023


Abstract

The emergence of Coronavirus disease 2019 (Covid-19) is a global problem nowadays, causing health difficulty with increasing mortality rates, which doesn't have a verified treatment. SARS-CoV-2 infection has various pathological and epidemiological characteristics, one of them is increased amounts of cytokine production, which in order activate an abnormal unrestricted response called “cytokine storm”. This event contributes to severe acute respiratory distress syndrome (ARDS), which results in respiratory failure and pneumonia and is the great cause of death associated with Covid-19. Endotoxemia and the release of bacterial lipopolysaccharides (endotoxins) from the lumen into the bloodstream enhance proinflammatory cytokines. SARS-CoV-2 can straightly interplay with endotoxins via its S protein, leading to the extremely elevating release of cytokines and consequently increase the harshness of Covid-19. In this review, we will discuss the possible role of viral-bacterial interaction that occurs through the transfer of bacterial products such as lipopolysaccharide (LPS) from the intestine into the bloodstream, exacerbating the severity of Covid-19 and cytokine storms. © 2022 Elsevier Ltd
Other Related Docs
5. Immune Responses to Corona Family Viruses and Vaccine Strategies, Journal of Isfahan Medical School (2020)
7. Chronic Low-Grade Inflammation: Etiology and Its Effects, Journal of Isfahan Medical School (2016)
11. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
12. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
14. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
17. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)